 | • レポートコード：B-GIR09D4213 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ヘルペス後神経痛治療の世界市場について調べ、まとめました。種類別セグメントは、薬物、パッチ、ステロイド注射剤等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。ヘルペス後神経痛治療の世界市場概観、企業動向、企業別ヘルペス後神経痛治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ヘルペス後神経痛治療の市場概観 ・ヘルペス後神経痛治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヘルペス後神経痛治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・ヘルペス後神経痛治療の世界市場規模 ・ヘルペス後神経痛治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・ヘルペス後神経痛治療のアメリカ市場規模推移 ・ヘルペス後神経痛治療のカナダ市場規模推移 ・ヘルペス後神経痛治療のメキシコ市場規模推移 ・ヘルペス後神経痛治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ヘルペス後神経痛治療のドイツ市場規模推移 ・ヘルペス後神経痛治療のイギリス市場規模推移 ・ヘルペス後神経痛治療のロシア市場規模推移 ・ヘルペス後神経痛治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ヘルペス後神経痛治療の日本市場規模推移 ・ヘルペス後神経痛治療の中国市場規模推移 ・ヘルペス後神経痛治療の韓国市場規模推移 ・ヘルペス後神経痛治療のインド市場規模推移 ・ヘルペス後神経痛治療の東南アジア市場規模推移 ・ヘルペス後神経痛治療の南米市場分析（ブラジル、アルゼンチン等） ・ヘルペス後神経痛治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ヘルペス後神経痛治療の種類別分析/販売量、売上、市場シェア（薬物、パッチ、ステロイド注射剤） ・ヘルペス後神経痛治療の用途別分析/市場規模（病院薬局、オンライン薬局、小売薬局） ・ヘルペス後神経痛治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ヘルペス後神経痛治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Scope of the Report:
The global Post Herpetic Neuralgia Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Post Herpetic Neuralgia Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Post Herpetic Neuralgia Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Post Herpetic Neuralgia Therapies market by product type and applications/end industries.
Market Segment by Companies, this report covers
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drugs
Patches
Steroid Injectable
Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Table of Contents
1 Post Herpetic Neuralgia Therapies Market Overview
1.1 Product Overview and Scope of Post Herpetic Neuralgia Therapies
1.2 Classification of Post Herpetic Neuralgia Therapies by Types
1.2.1 Global Post Herpetic Neuralgia Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Types in 2018
1.2.3 Drugs
1.2.4 Patches
1.2.5 Steroid Injectable
1.3 Global Post Herpetic Neuralgia Therapies Market by Application
1.3.1 Global Post Herpetic Neuralgia Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Post Herpetic Neuralgia Therapies Market by Regions
1.4.1 Global Post Herpetic Neuralgia Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Post Herpetic Neuralgia Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Endo Pharmaceuticals
2.1.1 Business Overview
2.1.2 Post Herpetic Neuralgia Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Depomed
2.2.1 Business Overview
2.2.2 Post Herpetic Neuralgia Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Acorda Therapeutics
2.3.1 Business Overview
2.3.2 Post Herpetic Neuralgia Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Post Herpetic Neuralgia Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Post Herpetic Neuralgia Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Daiichi Sankyo
2.6.1 Business Overview
2.6.2 Post Herpetic Neuralgia Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Teikoku Pharma
2.7.1 Business Overview
2.7.2 Post Herpetic Neuralgia Therapies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Post Herpetic Neuralgia Therapies Market Competition, by Players
3.1 Global Post Herpetic Neuralgia Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Post Herpetic Neuralgia Therapies Players Market Share
3.2.2 Top 10 Post Herpetic Neuralgia Therapies Players Market Share
3.3 Market Competition Trend
4 Global Post Herpetic Neuralgia Therapies Market Size by Regions
4.1 Global Post Herpetic Neuralgia Therapies Revenue and Market Share by Regions
4.2 North America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
5 North America Post Herpetic Neuralgia Therapies Revenue by Countries
5.1 North America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
5.2 USA Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
6 Europe Post Herpetic Neuralgia Therapies Revenue by Countries
6.1 Europe Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
6.2 Germany Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
6.4 France Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Countries
7.1 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
7.2 China Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
7.5 India Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
8 South America Post Herpetic Neuralgia Therapies Revenue by Countries
8.1 South America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
8.2 Brazil Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Post Herpetic Neuralgia Therapies by Countries
9.1 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
10 Global Post Herpetic Neuralgia Therapies Market Segment by Type
10.1 Global Post Herpetic Neuralgia Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2014-2024)
10.4 Patches Revenue Growth Rate (2014-2024)
10.5 Steroid Injectable Revenue Growth Rate (2014-2024)
11 Global Post Herpetic Neuralgia Therapies Market Segment by Application
11.1 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2014-2019)
11.2 Post Herpetic Neuralgia Therapies Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Online Pharmacies Revenue Growth (2014-2019)
11.5 Retail Pharmacies Revenue Growth (2014-2019)
12 Global Post Herpetic Neuralgia Therapies Market Size Forecast (2019-2024)
12.1 Global Post Herpetic Neuralgia Therapies Market Size Forecast (2019-2024)
12.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Regions (2019-2024)
12.3 North America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
12.6 South America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Post Herpetic Neuralgia Therapies Picture
Table Product Specifications of Post Herpetic Neuralgia Therapies
Table Global Post Herpetic Neuralgia Therapies and Revenue (Million USD) Market Split by Product Type
Figure Global Post Herpetic Neuralgia Therapies Revenue Market Share by Types in 2018
Figure Drugs Picture
Figure Patches Picture
Figure Steroid Injectable Picture
Table Global Post Herpetic Neuralgia Therapies Revenue (Million USD) by Application (2014-2024)
Figure Post Herpetic Neuralgia Therapies Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Retail Pharmacies Picture
Table Global Market Post Herpetic Neuralgia Therapies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Table Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Type and Applications
Table Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Depomed Basic Information, Manufacturing Base and Competitors
Table Depomed Post Herpetic Neuralgia Therapies Type and Applications
Table Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics Post Herpetic Neuralgia Therapies Type and Applications
Table Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Post Herpetic Neuralgia Therapies Type and Applications
Table Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Post Herpetic Neuralgia Therapies Type and Applications
Table Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Post Herpetic Neuralgia Therapies Type and Applications
Table Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Teikoku Pharma Basic Information, Manufacturing Base and Competitors
Table Teikoku Pharma Post Herpetic Neuralgia Therapies Type and Applications
Table Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Post Herpetic Neuralgia Therapies Revenue (Million USD) by Players (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue Share by Players (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Players in 2017
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Players in 2018
Figure Global Top 5 Players Post Herpetic Neuralgia Therapies Revenue Market Share in 2018
Figure Global Top 10 Players Post Herpetic Neuralgia Therapies Revenue Market Share in 2018
Figure Global Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue (Million USD) by Regions (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Market Share by Regions in 2018
Figure North America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Europe Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure South America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table North America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
Table North America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries in 2018
Figure USA Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Canada Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Mexico Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table Europe Post Herpetic Neuralgia Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Post Herpetic Neuralgia Therapies Revenue Market Share by Countries in 2018
Figure Germany Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure UK Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure France Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Russia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Italy Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Post Herpetic Neuralgia Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Share by Countries in 2018
Figure China Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Japan Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Korea Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure India Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table South America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
Table South America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Post Herpetic Neuralgia Therapies Revenue Market Share by Countries in 2018
Figure Brazil Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Argentina Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Colombia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Post Herpetic Neuralgia Therapies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure UAE Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Egypt Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure Nigeria Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Figure South Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue (Million USD) by Type (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue Share by Type (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Type (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Type in 2019
Table Global Post Herpetic Neuralgia Therapies Revenue Forecast by Type (2019-2024)
Figure Global Post Herpetic Neuralgia Therapies Market Share Forecast by Type (2019-2024)
Figure Global Drugs Revenue Growth Rate (2014-2019)
Figure Global Patches Revenue Growth Rate (2014-2019)
Figure Global Steroid Injectable Revenue Growth Rate (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue by Application (2014-2019)
Table Global Post Herpetic Neuralgia Therapies Revenue Share by Application (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Application (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue Share by Application in 2019
Table Global Post Herpetic Neuralgia Therapies Revenue Forecast by Application (2019-2024)
Figure Global Post Herpetic Neuralgia Therapies Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Post Herpetic Neuralgia Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Post Herpetic Neuralgia Therapies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Post Herpetic Neuralgia Therapies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
Figure Europe Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
Figure South America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
世界のヘルペス後神経痛パッチ市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The patch is applied after a PHN patient's skin has been pretreated with a local anesthetic or an oral analgesic. Scope of the Report: The worldwide market for Post Herpetic Neuralgia …- 世界のヘルペス後神経痛薬市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antivi…
- 世界の重症筋無力症治療市場予測（～2024年） Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs. Scope of the Report: The global Myasthenia Gravis Therapies market is valued at xx million USD …
- 世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
- 世界の血液療法市場予測（～2024年） Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood. Scope of the Report: The global Hematology Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR …